Cargando…

Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson’s disease

Beyond classical motor symptoms, motivational and affective deficits are frequently observed in Parkinson’s disease (PD), dramatically impairing the quality of life of patients. Using bilateral 6-hydroxydopamine (6-OHDA) lesions of the substantia nigra pars compacta (SNc) in rats, we have been able...

Descripción completa

Detalles Bibliográficos
Autores principales:	Favier, Mathieu, Carcenac, Carole, Drui, Guillaume, Vachez, Yvan, Boulet, Sabrina, Savasta, Marc, Carnicella, Sebastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278505/ https://www.ncbi.nlm.nih.gov/pubmed/28134302 http://dx.doi.org/10.1038/srep41589

Ejemplares similares

Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits
por: Carnicella, S, et al.
Publicado: (2014)

Nigrostriatal Dopaminergic Denervation Does Not Promote Impulsive Choice in the Rat: Implication for Impulse Control Disorders in Parkinson’s Disease
por: Magnard, Robin, et al.
Publicado: (2018)

What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?
por: Magnard, R, et al.
Publicado: (2016)

High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson’s disease
por: Favier, Mathieu, et al.
Publicado: (2013)

Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats
por: Goutaudier, Raphaël, et al.
Publicado: (2020)

DREADDs: The Power of the Lock, the Weakness of the Key. Favoring the Pursuit of Specific Conditions Rather than Specific Ligands
por: Goutaudier, Raphaël, et al.
Publicado: (2019)

A metabolic biomarker predicts Parkinson’s disease at the early stages in patients and animal models
por: Mallet, David, et al.
Publicado: (2022)

Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkers
por: Dufourd, Thibault, et al.
Publicado: (2019)

Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol use
por: Goutaudier, Raphaël, et al.
Publicado: (2022)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari, Szabolcs, et al.
Publicado: (2017)

Chronic Musculoskeletal Pain Moderates the Association between Sleep Quality and Dorsostriatal-Sensorimotor Resting State Functional Connectivity in Community-Dwelling Older Adults
por: Montesino-Goicolea, Soamy, et al.
Publicado: (2022)

Neuropsychiatric Symptoms in an Inpatient Parkinson's Disease Sample
por: McLaughlin, Nicole C. R., et al.
Publicado: (2014)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Neuropsychiatric Symptoms and Caregiver Burden in Parkinson's Disease
por: Juneja, Abhishek, et al.
Publicado: (2020)

Interplay between gait and neuropsychiatric symptoms in Parkinson’s Disease
por: Russo, Michela, et al.
Publicado: (2022)

Mapping Chemical Elements and Iron Oxidation States in the Substantia Nigra of 6-Hydroxydopamine Lesioned Rats Using Correlative Immunohistochemistry With Proton and Synchrotron Micro-Analysis
por: Carmona, Asuncion, et al.
Publicado: (2019)

Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
por: Leroi, Iracema, et al.
Publicado: (2012)

Deep Brain Stimulation of the Subthalamic Nucleus Modulates Reward-Related Behavior: A Systematic Review
por: Vachez, Yvan M., et al.
Publicado: (2020)

Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are Associated with Increased Caregiver Burden
por: Oh, Yoon-Sang, et al.
Publicado: (2015)

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
por: Weintraub, Daniel, et al.
Publicado: (2020)

Neuropsychiatric Symptoms and Caregiver Burden in Parkinson's Disease: Mitigating the Lack of Awareness!
por: Nene, Devavrat, et al.
Publicado: (2020)

Contribution of neuropsychiatric symptoms in Parkinson’s disease to different domains of caregiver burden
por: Chahine, L. M., et al.
Publicado: (2021)

Neuropsychiatric Symptoms in Clinically Defined Parkinson's Disease: An Updated Review of Literature
por: Macías-García, Paloma, et al.
Publicado: (2022)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms
por: Meng, Detao, et al.
Publicado: (2023)

Motivational disturbances in rodent models of neuropsychiatric disorders
por: Canonica, Tara, et al.
Publicado: (2022)

Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation
por: Liu, Weibing, et al.
Publicado: (2021)

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?
por: Houeto, Jean-Luc, et al.
Publicado: (2016)

Biweekly fluctuations of neuropsychiatric symptoms according to the Neuropsychiatric Inventory: Erratic symptoms or scores?
por: Eikelboom, Willem S., et al.
Publicado: (2022)

What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
por: Bergamini, Giorgio, et al.
Publicado: (2022)

Erratum: Motivational disturbances in rodent models of neuropsychiatric disorders
Publicado: (2023)

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)
por: Dlay, J. K., et al.
Publicado: (2020)

Predicting the Severity of Parkinson’s Disease Dementia by Assessing the Neuropsychiatric Symptoms with an SVM Regression Model
por: Byeon, Haewon
Publicado: (2021)

Symptom dimensions of anxiety in Parkinson’s disease: Replication study in a neuropsychiatric patient population
por: Rutten, Sonja, et al.
Publicado: (2021)

The Effects of Rivastigmine on Neuropsychiatric Symptoms in the Early Stages of Parkinson's Disease: A Systematic Review
por: Reilly, Siobhan, et al.
Publicado: (2023)

Neuropsychiatric symptoms and celiac disease
por: Urban-Kowalczyk, Małgorzata, et al.
Publicado: (2014)

Neuropsychiatric symptoms and severity of dementia
por: Caldas, Gustavo Henrique de Oliveira, et al.
Publicado: (2013)

Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease Patients
por: Hidding, U., et al.
Publicado: (2017)

The site of stimulation moderates neuropsychiatric symptoms after subthalamic deep brain stimulation for Parkinson's disease
por: Mosley, Philip E., et al.
Publicado: (2018)

Risk factors for neuropsychiatric symptoms in patients with Parkinson’s disease during COVID-19 pandemic in Japan
por: Kitani-Morii, Fukiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0jhinf5mkm1ktao2ba6m62upuo